NK cells can kill cancer cells by CD16A(FcgRIIIA)-mediated antibody-dependent cellular toxicity (ADCC), as NK cells can act a bridge between the anti-tumor antibodies IgG1 and IgG3, whereby Fab specifically recognizes the tumor while the Fc segment bind to the natural killer cell [18]. Here, FCGR3A is linked to neoplasm.